Ingrid Delaet

General Counsel at NEUROCRINE BIOSCIENCES, INC.

Net worth: 3 M $ as of 2026-08-30

60 year

Health Technology

Consumer Services

Profile

Dr. Ingrid Delaet is a Chief Regulatory Officer at Neurocrine Biosciences, Inc. Dr. Delaet was previously employed as a Senior Vice President-Regulatory Affairs by Intercept Pharmaceuticals, Inc., a Global Regulatory Affairs by Bristol Myers Squibb Co., a Head-Clinical Research by CellPro, Inc., and a Head-Clinical Research by Wyeth-Ayerst Research.
She received her graduate degree from Université Libre de Bruxelles and a doctorate degree from Université Libre de Bruxelles.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NEUROCRINE BIOSCIENCES, INC. 0.02%	2026-09-10	18,289 ( 0.02% )	3 M $	2026-08-30

Ingrid Delaet active positions

Companies	Position	Start
NEUROCRINE BIOSCIENCES, INC.	General Counsel	2020-12-31

All active positions of Ingrid Delaet

Former positions of Ingrid Delaet

Companies	Position	End
INTERCEPT PHARMACEUTICALS, INC.	General Counsel	2020-12-31
BRISTOL-MYERS SQUIBB COMPANY	General Counsel	2016-08-31
Wyeth-Ayerst Research	Corporate Officer/Principal	-
CellPro, Inc. CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company	Corporate Officer/Principal	-

See the detail of Ingrid Delaet's experience

Training of Ingrid Delaet

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ingrid Delaet's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders	Health Technology
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases	Health Technology
CellPro, Inc. CellPro, Inc. BiotechnologyHealth Technology Operates as biotechnology company	Health Technology
Université Libre de Bruxelles Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Wyeth-Ayerst Research